CAT No: CP26707
CAS No:201335-88-8
Synonyms/Alias:201335-88-8;FMOC-D-TYR(ME)-OH;Fmoc-O-Methyl-D-Tyrosine;Fmoc-4-Methoxy-D-Phenylalanine;D-Tyrosine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-methyl-;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(4-methoxyphenyl)propanoic acid;(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-methoxyphenyl)propanoic acid;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-(4-methoxyphenyl)propanoic acid;FMOC-4-METHOXY-D-PHE-OH;FMOC-D-4-METHOXYPHE;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methoxyphenyl)propanoic acid;(2R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methoxyphenyl)propanoic acid;MFCD00237393;N-Fmoc-O-methyl-D-tyrosine;SCHEMBL2310128;DTXSID30427180;Fmoc-D-Tyr(Me)-OH, AldrichCPR;AKOS015837397;HY-W022227;DS-13636;CS-0040948;A50176;EN300-3395151;887-716-4;
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.